NAS:CRVS (USA) Germany

Corvus Pharmaceuticals Inc $ 0 -0.04 (-1%)

Volume:
0
Avg Vol (1m):
1,251,242
Market Cap $:
111.02 Mil
Enterprise Value $:
54.52 Mil
P/E (TTM):
0.00
P/B:
2.18
Warning! GuruFocus has detected 1 Severe warning sign with CRVS. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

Financial Strength

Current Vs Industry Vs History
Cash-To-Debt 21.47
Debt-to-Equity 0.05
Debt-to-EBITDA -0.06
Piotroski F-Score 2
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
ROIC -906.04 %
WACC 13.34 %

Profitability Rank

Current Vs Industry Vs History
ROE % -64.76
ROA % -54.65
ROC (Joel Greenblatt) % -1241.26
3-Year EBITDA Growth Rate 11.4
3-Year EPS without NRI Growth Rate 12.3

Valuation Rank

Current Vs Industry Vs History
PB Ratio 2.18
EV-to-EBIT -1.14
EV-to-EBITDA -1.16
Current Ratio 5.24
Quick Ratio 5.24

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.1

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 2.19
Earnings Yield (Greenblatt) % -86.49